Trinias MiX-Package

Shorter treatment times and less contrast media

In the year of its 140th anniversary, Shimadzu has released the new Trinias MiX package (Minimally invasive eXperience) to support less invasive treatments through a variety of applications. The Trinias MiX package is an exten¬sion of the Trinias angiography system, which facilitates high-level interventions through proprietary image processing technology. Shimadzu provides functional enhancements, such as newly developed 3D application, the trace mapping function, and the PCI support application. As a result, shorter treatment times are achieved and less contrast media is used.

Trinias F12 MiX package Floor-Mounted C-Arm Type provides functional...
Trinias F12 MiX package Floor-Mounted C-Arm Type provides functional enhancements which achieve shorter treatment times and less contrast media.
Source: Shimadzu

The 3D application allows the angiography system to be linked to previously acquired CT images during the interventional procedure. The trace mapping function au-tomatically extracts and displays only the outline of vessel walls providing a map image for easy device guidance. In addition, the PCI (Percutaneous Coronary Intervention) Support application can display stents in a fixed position in real-time. Furthermore, thanks to the SCORE PRO Advance image-processing engine, the system now can operate at about half the conventional X-ray dose. Together, these support more user-friendly treatment, with less burden on patients.

Minimally invasive procedures

In comparison to invasive surgical procedures, minimally invasive procedures use a catheter (a small tube for medical procedures), which is inserted into a blood vessel through a small incision in the skin. X-ray fluoroscopy is used during the procedure to guide the catheter and deploy devices. Endovascular therapy is less invasive and more patient-friendly and as a result, widely used in the context of a heightened awareness of the Quality of Life (QOL).

Angiography systems must provide high imaging quality and ease of operation to support the practitioner during procedures. It is expected that advances in stents and other endovascular therapeutic devices in recent years, as well as the establishment of various interventional procedures will further reduce the burden on patients.

Features of the New Package

The Trinias MiX-Package functional enhancements cover the following therapeutic support applications:

1. SCORE Navi + Plus 3D Application interlinked with CT images

With this application, pre-procedure CT images can be imported to the work-station, enabling an overlay with fluoroscopy, including angular synchronization with the angiography system C-arm. Linking the CT images directly to the treatment images allows a seamless flow from pre-procedural therapeutic design to navigation during the procedure.

2. SCORE StentView + Plus PCI Support Application improves device detec-tion efficiency

This is the more advanced version of Shimadzu's proprietary SCORE StentView application to support safe and reliable PCI. In addition to a function allowing stents, which are in constant motion due to heartbeats, to be enhanced and dis¬played in a fixed position in real-time, a new function has been added to configure the region of interest (ROI) from the preceding fluoroscopy image. Narrow¬ing the detection area on the fluoroscopy image dramatically improves the device detection efficiency, even in procedures using multiple devices, thereby shortening treatment times.

3. SCORE MAP provides automatic trace mapping for aortic stent grafting

This newly developed trace mapping function automatically extracts only the outline of vascular walls based on DSA  images. Overlaying this with fluoroscopy images dramatically increases the visibility of wires and devices. This is useful in endovascular treatments in the aorta, where contrast concentration uniformity is particularly problematic, while helping to reduce contrast media use. In addition, the mapping region can be narrowed and sketched by the practitioners themselves, supporting more efficient procedures.


Source: Shimadzu

05.11.2015

More on the subject:More on companies:
Read all latest stories

Related articles

Photo

Chemotherapy

5-FluoroUracil: Curing or killing the patient?

Fluoropyrimidine-based chemotherapies are widely used, at least in the European area, for treating various types of cancer including digestive, breast, throat and brain cancer. Fluoropyrimidines are…

Photo

Shimadzu Europa 50th anniversary

Mass spectrometry and ever more…

As Shimadzu celebrates its 50th anniversary in Europe, we spoke with Stéphane Moreau, Manager of LC-MS & Life Sciences at the Marketing Europe/Analytical Business Unit of Shimadzu Europa GmbH,…

Photo

Liquid chromatography-mass spectrometry

Increasing productivity and throughput in the lab

Liquid chromatography-mass spectrometry (LC-MS) has become a highly valued procedure in state-of-the-art laboratories – among them the Dr. Wisplinghoff Laboratory in Cologne, which adopted the…

Related products

Shimadzu – Axima iDplus Assurance

Mass Spectrometry

Shimadzu – Axima iDplus Assurance

Shimadzu Europa GmbH
Shimadzu – Axima iDplus Confidence

Mass Spectrometry

Shimadzu – Axima iDplus Confidence

Shimadzu Europa GmbH
Shimadzu – Axima iDplus Performance

Mass Spectrometry

Shimadzu – Axima iDplus Performance

Shimadzu Europa GmbH
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Shimadzu – Flexavision F3

Flatpanel Fluoro

Shimadzu – Flexavision F3

Shimadzu Europa GmbH
Shimadzu – Flexavision series

Fluoroscopy

Shimadzu – Flexavision series

Shimadzu Europa GmbH